State officials said Indiana's lack of access to obstetrics care is growing, which is driving the state's high infant and maternal mortality rates. Some lawmakers said more funding and better Medicaid reimbursements could help keep birthing centers open.

Untreated mental health cost Indiana $4.2 billion in 2019. The state has adopted a new law in an attempt to make it more accessible. But many people still endure barriers to seeking treatment.

A legislative committee directed to make recommendations on the states Medicaid program approved its final report without any recommendations. The committee chair says their work will inform recommendations ahead of planning for the 2025 state budget.

A committee of state lawmakers unanimously agreed on seven recommendations to address Indianas high health care costs. The final report by the Health Care Cost Oversight Task Force covers a wide range of policy topics, but the recommendations focus on increased transparency across the health care industry.

Survivors of nonfatal shootings do not always seek professional mental health help despite trauma, according to a new study. Stigma and fear of getting in trouble are some of the reasons why.

The Indiana Family and Social Services Administration is applying for a new Medicaid waiver that would expand access to nursing facility alternatives. The waiver will be open to public comment until Dec. 14.

Indianas former abortion care providers are taking new aim at the states near-total abortion ban following their loss at the state Supreme Court earlier this year.

Across the Kansas City metro, departments are making strategic efforts to rebuild since COVID and prepare for future health emergencies. But they are fighting uphill battles against lackluster funding, a mass exodus of employees and public perception.

IU Health awarded $9.6 million in grant money to 14 community partners which will help address social and environmental issues that affect peoples health.

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of Ozempic. Short supply and high costs have limited access to both medications. The FDA approved the new drug for people considered obese or for those who are overweight and have a weight-related health condition.